Keros Therapeutics, Inc. (KROS)

19.43 -0.10 (-0.51%) USD  |  NASDAQ  |  Jan 15, 11:14
More

Keros Therapeutics Rent and Landing Expense (Quarterly)

Rent and Landing Expense (Quarterly) Chart

View Rent and Landing Expense (Quarterly) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Rent and Landing Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Rent and Landing Expense (Quarterly) Range, Past 5 Years

View Rent and Landing Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Rent and Landing Expense (Quarterly) Benchmarks

View Rent and Landing Expense (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. --
Pfizer Inc. --
Innoviva, Inc. Upgrade
Ocugen, Inc. --
Bionano Genomics, Inc. --